Avanafil for the treatment of erectile dysfunction: a multicenter, randomized, double-blind study in men with diabetes mellitus
about
Phosphodiesterase-5 inhibitors for erectile dysfunction in patients with diabetes mellitus: A systematic review and meta-analysis of randomized controlled trialsAvanafil for male erectile dysfunction: a systematic review and meta-analysis.Avanafil for erectile dysfunction.Avanafil for the treatment of erectile dysfunction: initial data and clinical key properties.Avanafil: a review of its use in patients with erectile dysfunction.Phosphodiesterase type 5 inhibitors: back and forward from cardiac indicationsSerum High-Sensitivity C-Reactive Protein Levels and Response to 5 mg Tadalafil Once Daily in Patients With Erectile Dysfunction and DiabetesTreatment strategies for diabetic patients suffering from erectile dysfunction: an update.How to treat erectile dysfunction in men with diabetes: from pathophysiology to treatment.Avanafil for erectile dysfunction in elderly and younger adults: differential pharmacology and clinical utility.Emerging drugs for the treatment of erectile dysfunction.Erectile dysfunction and its management in patients with diabetes mellitus.The safety of phosphodiesterase type 5 inhibitors for erectile dysfunction.Avanafil - a further step to tailoring patient needs and expectations.Avanafil for the treatment of erectile dysfunction.Modulation of Dopaminergic Pathways to Treat Erectile Dysfunction.Advances in pharmacotherapy for erectile dysfunction and associated cardiac impact.An open-label, long-term evaluation of the safety, efficacy and tolerability of avanafil in male patients with mild to severe erectile dysfunction.[Avanafil for the treatment of erectile dysfunction in practice. Non-interventional study AVANTI].
P2860
Q26800403-3A1E7B34-CBF0-4BF0-9E11-000852324800Q33621456-0BCF2BC2-BE41-4CA6-A15E-51589A687DB2Q34039001-B759A9CD-9AA3-4736-9333-85D5D94E8E95Q34570803-C049E60A-A368-4E07-B70B-BCF67B4E77E1Q34655442-9F5FB5B1-FBE9-4CA8-BD9C-E8270EB78896Q36460566-A64310E8-6A6B-44A4-9B3B-4F6BEEBFA2CDQ37399581-A4B61D51-1A1D-422C-9E1C-B3D46D1BB40DQ38224353-CE43A7B3-23C1-4B40-975D-53A115EEF09DQ38246404-8779EC54-ACBF-4DB3-A363-60FA457D1143Q38248275-F15D4A71-8CE8-49B4-9F63-2E2033C434A4Q38367700-523CFAB2-1B6C-4B6A-BD44-99599935609EQ38615555-0C6C1488-B6A4-4575-A7C5-5ED8E091D726Q38692296-84FFF167-B8CB-41B2-B639-AB746EDEE2CCQ38846047-034EDBE4-8819-48A5-BD0C-687206C4D1A8Q38896836-BBD774C4-E938-4B35-B5DE-50FC1EFFBC05Q38931983-E5097E15-7EFB-42A6-B23C-912DF644C468Q38966016-90CBE10F-DD14-42CA-B4DF-9E5691F17E83Q42693466-5272F4EB-C570-47D8-B6C8-A6E8CD5637BAQ52837854-EA78F31A-BF46-42C6-A456-003B84AF3ACE
P2860
Avanafil for the treatment of erectile dysfunction: a multicenter, randomized, double-blind study in men with diabetes mellitus
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Avanafil for the treatment of ...... in men with diabetes mellitus
@en
type
label
Avanafil for the treatment of ...... in men with diabetes mellitus
@en
prefLabel
Avanafil for the treatment of ...... in men with diabetes mellitus
@en
P2093
P2860
P1476
Avanafil for the treatment of ...... in men with diabetes mellitus
@en
P2093
Brenda A Trask
Charles H Bowden
Craig A Peterson
Gary S Karlin
Irwin Goldstein
Laurence H Belkoff
LeRoy A Jones
Wesley W Day
P2860
P304
P356
10.1016/J.MAYOCP.2012.06.016
P407
P577
2012-08-01T00:00:00Z